Live tape
Top 8, mentions 7d11,446SPCX2,425 mentions▲ +0.08GOOGL1,984 mentions▲ +0.02META1,790 mentions▲ +0.04TSLA1,703 mentions▲ +0.05NFLX973 mentions▲ +0.03QQQ886 mentions▲ +0.05AMZN843 mentions▲ +0.06NVDA842 mentions▲ +0.06

Equity · Healthcare

ZLAB

NASDAQ

Zai Lab (ZLAB)

$20 −3.66% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for ZLAB to draw a line in its place.

Track this symbol on TradingView TradingView chart
Market cap $22.2B
52-week range $16.32 – $40.56
Avg volume 216.8K

as of Jul 17, 2026

Zai Lab (ZLAB) insider trades

SEC Form 4 · last 90 days · newest reported trade 19 Aug 2026

In the 90 days to 26 Oct 2026, Zai Lab insiders reported 3 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 1 Jul 2026.

Open-market buys 0
Open-market sells 3
Net sold $235K
Non-trade filings 4
Date Insider Type Shares Value
19 Aug 2026 Chen Yajing Chief Financial Officer Sell 260 $7K
12 Aug 2026 Lis William Director Sell 8,506 $213K
11 Aug 2026 Chen Yajing Chief Financial Officer Sell 619 $15K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
01 Oct 2026 Chen Yajing Chief Financial Officer Option exercise 920
01 Oct 2026 Chen Yajing Chief Financial Officer Tax withheld 315 $8K
14 Aug 2026 Chen Yajing Chief Financial Officer Option exercise 1,250
14 Aug 2026 Chen Yajing Chief Financial Officer Tax withheld 427 $11K

Zai Lab (ZLAB) reported financials

SEC EDGAR XBRL SEC EDGAR

Zai Lab reported revenue of $457.2M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$175.5M.

Figure Reported Period
Revenue $457.2M 31 Dec 2025 fiscal year
Net income −$175.5M 31 Dec 2025 fiscal year
Diluted EPS −$0.16 31 Dec 2025 fiscal year
Total assets $1.1B 30 Jun 2026 at period end
Total equity $607.0M 30 Jun 2026 at period end

Zai Lab (ZLAB) earnings

SEC EDGAR

Zai Lab last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.05; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.05 $106M
31 Mar 2026 Q1 2026 −$0.05 $100M
31 Dec 2025 FY 2025 −$0.16 $460M
30 Sep 2025 Q3 2025 −$0.03 $116M
30 Jun 2025 Q2 2025 −$0.04 $110M
31 Mar 2025 Q1 2025 −$0.04 $106M
31 Dec 2024 FY 2024 −$0.26 $399M
30 Sep 2024 Q3 2024 −$0.04 $102M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Zai Lab (ZLAB) institutional holders (13F)

SEC Form 13F SEC EDGAR

4 of the 45 institutional funds we track reported a Zai Lab position for the quarter ended 30 Jun 2026 — a combined $54.6M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Two Sigma Investments Added +319.5% shares 1,299,394 $24.7M
Citadel Advisors Held (±25%) −23.9% shares 1,284,706 $24.4M
Marshall Wace New position 147,217 $2.8M
D. E. Shaw & Co. Added +123.2% shares 141,158 $2.7M
Point72 Asset Management Exited
Renaissance Technologies Exited

Zai Lab (ZLAB) fails-to-deliver

SEC CNS data SEC

On 25 Sep 2026, 4,000 shares of Zai Lab failed to deliver (about $101K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
25 Sep 2026 4,000 $101K <0.001%
24 Sep 2026 17,832 $471K 0.002%
21 Sep 2026 1,344 $35K <0.001%
14 Sep 2026 4,740 $114K <0.001%
11 Sep 2026 2,240 $54K <0.001%

Zai Lab (ZLAB): frequently asked questions

From live data

Have Zai Lab insiders bought or sold shares recently?

In the 90 days to 26 Oct 2026, Zai Lab insiders reported 3 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 1 Jul 2026. A further 4 filings were grants, awards, gifts or exercises rather than open-market trades.

How many institutions hold Zai Lab?

4 of the 45 institutional funds we track reported a Zai Lab position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Zai Lab had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Zai Lab is dated 25 Sep 2026, when 4,000 shares failed to deliver.

When did Zai Lab last report earnings?

Zai Lab last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.05; no next date is announced in SEC filings yet.

What exchange is Zai Lab listed on?

Zai Lab trades on NASDAQ under the ticker ZLAB.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARValuation computed from SEC EDGAR filings